Ken Griffin’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$85.2M Sell
982,741
-4,246,447
-81% -$407M 0.01% 921
2025
Q4
$502M Buy
5,229,188
+1,527,713
+41% +$148M 0.08% 188
2025
Q3
$353M Sell
3,701,475
-6,095,380
-62% -$560M 0.05% 282
2025
Q2
$854M Buy
9,796,855
+1,135,688
+13% +$96.3M 0.15% 85
2025
Q1
$778M Buy
8,661,167
+2,691,162
+45% +$241M 0.15% 70
2024
Q4
$477M Buy
5,970,005
+148,840
+3% +$12.9M 0.08% 156
2024
Q3
$524M Buy
5,821,165
+4,769,249
+453% +$401M 0.1% 127
2024
Q2
$82.8M Buy
1,051,916
+296,039
+39% +$24.3M 0.02% 793
2024
Q1
$65.9M Buy
755,877
+700,512
+1,265% +$59.8M 0.01% 1005
2023
Q4
$4.56M Sell
55,365
-432,058
-89% -$32.9M ﹤0.01% 3928
2023
Q3
$38.2M Sell
487,423
-947,547
-66% -$79.3M 0.01% 1291
2023
Q2
$126M Buy
1,434,970
+993,802
+225% +$85.6M 0.03% 492
2023
Q1
$35.6M Sell
441,168
-227,321
-34% -$18.5M 0.01% 1376
2022
Q4
$52M Buy
668,489
+200,726
+43% +$16.3M 0.01% 1098
2022
Q3
$37.8M Sell
467,763
-112,277
-19% -$10.1M 0.01% 1282
2022
Q2
$52.1M Buy
580,040
+455,868
+367% +$46.2M 0.01% 989
2022
Q1
$13.8M Sell
124,172
-484,289
-80% -$51.2M ﹤0.01% 2485
2021
Q4
$62.9M Buy
608,461
+403,920
+197% +$46.8M 0.01% 989
2021
Q3
$25.6M Buy
204,541
+52,296
+34% +$6.77M 0.01% 1718
2021
Q2
$18.9M Sell
152,245
-2,802,561
-95% -$352M ﹤0.01% 2157
2021
Q1
$349M Buy
2,954,806
+133,403
+5% +$15.6M 0.09% 144
2020
Q4
$330M Buy
2,821,403
+54,225
+2% +$5.97M 0.09% 139
2020
Q3
$288M Sell
2,767,178
-33,169
-1% -$3.33M 0.08% 120
2020
Q2
$257M Buy
2,800,347
+1,781,209
+175% +$171M 0.09% 121
2020
Q1
$91.9M Sell
1,019,138
-1,266,961
-55% -$135M 0.04% 366
2019
Q4
$259M Buy
2,286,099
+1,945,474
+571% +$213M 0.11% 124
2019
Q3
$37M Sell
340,625
-131,148
-28% -$13.7M 0.02% 976
2019
Q2
$45.9M Sell
471,773
-688,981
-59% -$62.9M 0.02% 777
2019
Q1
$106M Sell
1,160,754
-2,836,116
-71% -$254M 0.05% 342
2018
Q4
$364M Buy
3,996,870
+1,619,083
+68% +$151M 0.2% 51
2018
Q3
$234M Buy
2,377,787
+1,956,640
+465% +$181M 0.1% 138
2018
Q2
$36.1M Buy
421,147
+221,982
+111% +$18.5M 0.02% 886
2018
Q1
$16M Sell
199,165
-305,191
-61% -$25.2M 0.01% 1306
2017
Q4
$40.7M Sell
504,356
-10,111
-2% -$810K 0.02% 735
2017
Q3
$40M Buy
514,467
+357,493
+228% +$29.7M 0.03% 660
2017
Q2
$13.9M Sell
156,974
-2,075,706
-93% -$175M 0.01% 1218
2017
Q1
$180M Buy
2,232,680
+2,066,161
+1,241% +$161M 0.16% 81
2016
Q4
$11.9M Buy
166,519
+138,545
+495% +$10.9M 0.01% 1237
2016
Q3
$2.42M Sell
27,974
-572,244
-95% -$49.9M ﹤0.01% 2748
2016
Q2
$52.1M Sell
600,218
-885,998
-60% -$71.6M 0.06% 320
2016
Q1
$111M Sell
1,486,216
-690,969
-32% -$52M 0.14% 105
2015
Q4
$167M Buy
2,177,185
+2,034,388
+1,425% +$153M 0.18% 95
2015
Q3
$9.56M Sell
142,797
-255,798
-64% -$18.8M 0.01% 1379
2015
Q2
$29.5M Sell
398,595
-844,710
-68% -$64.5M 0.03% 775
2015
Q1
$97M Sell
1,243,305
-828,478
-40% -$62.8M 0.09% 235
2014
Q4
$150M Buy
2,071,783
+467,165
+29% +$32.5M 0.15% 104
2014
Q3
$99.4M Sell
1,604,618
-807,509
-33% -$51.3M 0.1% 193
2014
Q2
$154M Buy
2,412,127
+2,196,780
+1,020% +$133M 0.18% 94
2014
Q1
$13.3M Buy
215,347
+106,302
+97% +$6.19M 0.02% 1097
2013
Q4
$6.26M Buy
109,045
+71,845
+193% +$4.07M 0.01% 1521
2013
Q3
$1.98M Sell
37,200
-65,806
-64% -$3.54M ﹤0.01% 2420
2013
Q2
$5.3M Buy
+103,006
New +$5.09M 0.01% 1516

Other funds holding MDT

Ken Griffin's MDT Position: Q1 2026 in Review

Ken Griffin reduced its Medtronic (MDT) stake by 81% in Q1 2026, selling an estimated $407M and leaving 982,741 shares worth $85.2M. The position accounts for 0.01% of the portfolio, ranked #921.

Ken Griffin first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $854M in Q2 2025. 2,239 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Ken Griffin held 982,741 shares of Medtronic worth $85.2M as of Q1 2026.
  • Ken Griffin sold 4,246,447 Medtronic shares in Q1 2026, an estimated $407M.
  • Medtronic made up 0.01% of Ken Griffin's portfolio in Q1 2026, its #921 holding.
  • Ken Griffin first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Ken Griffin's Medtronic position peaked at $854M in Q2 2025.
  • 2,239 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.